CARISA COX: Open Payments
NPI 1588343917 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 38 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $686 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $246 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| PFIZER INC. | 2 | $46 |
| Axsome Therapeutics, Inc. | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, FARXIGA, REXULTI, CAPLYTA, NURTEC ODT, Auvelity, QULIPTA, TRINTELLIX.
Industry payments across NE — which companies pay providers there.
